Confidentiality and Protection of Medication Error Reporting
Consumers want and deserve to be confident in the safety of the health care system. Programs designed to reduce medication errors are necessary to achieve optimal patient care and meet the public demand for a safer health care system.
AMCP supports a medication error reporting system that encourages participation while providing confidentiality and protection of the information reported and the person(s) reporting. This system should include processes to detect and correct errors, identify trends or patterns and encourage changes to the medication delivery process to reduce the potential for future errors.
- Medication error reporting programs should detect, correct and prevent errors, and result in a reduction in adverse events associated with medication errors.
- In order to encourage participation, error reporting programs should protect against civil discovery of the reported information.
- A disclosure of information may be permitted in a criminal proceeding, but only if the information to be disclosed is material to the proceeding, is not available from any other source, and is in the public interest.
- Error reporting programs must provide adequate safeguards against breaches of the privacy of the system along with penalties for those who commit such breaches.
- Explicit protection should be provided for information shared if a "national databank" is created, as well as for transmission of error data across state lines. Federal protections should pre‐empt less stringent state laws.
AMCP Where We Stand series: https://www.amcp.org/policy-advocacy/policy-advocacy-focus-areas/where-we-stand-position-statements
Approved by the AMCP Board of Directors, August 2011